TRPV1 and endometrial cancer: The potential answer lies in the involvement of non-classical cannabinoid receptors (i.e., TRPV1 for AEA) [21], as has been demonstrated in endometrial cancer cell lines [16] and in several other cancers [22,23,24,25,26,27], thereby affecting the balance between cell growth and apoptosis (programmed cell death).